Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Esophageal Squamous Cell Carcinoma (ESCC) · Locally Advanced Unresectable Esophageal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
Contact: Study coordinator (Shau-Hsuan Li) · lee056058@gmail.com · 0975-056058
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
Contact: Study coordinator (Yao-Kuang Wang) · minicawu@gmail.com · 07-3121101#7451
China Medical University Hospital, Taichung, Taiwan
Contact: Study coordinator (Ming-Yu Lien) · leinmirain@hotmail.com · 0975680832
Taichung Veterans General Hospital, Taichung, Taiwan
Contact: Study coordinator (Cheng-Wei Chou, MD) · ccwei@vghtc.gov.tw · +886-4-2359-2525 ext. 3175
National Cheng Kung University Hospital, Tainan, Taiwan
Contact: Study coordinator (Chia-Jui Yen) · yencj@mail.ncku.edu.tw · 06-2353535-6550
National Taiwan University Hospital, Taipei, Taiwan
Contact: Study coordinator (Chih-Hung Hsu, MD) · chihhunghsu@ntu.edu.tw · 886-2-2312-3456 ext. 67680
Taipei Veterans General Hospital, Taipei, Taiwan
Contact: Study coordinator (Ming-Huang Chen) · lweisiou@gmail.com · 02-28757529
Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
Contact: Study coordinator (Ming-Mo Hou, MD) · student871029@gmail.com · 0975-366138

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma

ESCC · Total Neoadjuvant Treatment · Pathological Complete Response

Abroad (travel likely)RecruitingPHASE2

Taipei, Taiwan

Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC

Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Xi'an, China

Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma (ESCC)

Abroad (travel likely)RecruitingPHASE2

Zunyi, China

KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer

Esophageal Squamous Cell Carcinoma (ESCC)

Abroad (travel likely)RecruitingPHASE2

Beijing, China